Inpatient and Outpatient Orderable

Prostate Health Index Build info

Synonyms

  • PROSTATE HEALTH INDEX (PHI) SERUM
  • PHI11
  • LAB11381

Short Name

PROSTATE HEALTH INDEX (PHI) SERUM

Procedure Master Number

LAB11381

Procedure ID

115105

Clinical Info

Aiding in distinguishing prostate cancer from benign prostate conditions in men with prostate-specific antigen (PSA) concentrations in the 4 to 10 ng/mL range and digital rectal examination (DRE) findings that are not suspicious for cancer
 

Prostatic biopsy is required for diagnosis of cancer.

Specimen Sources

 Blood, Arterial Blood, Capillary Blood, Central Line Blood, Venous

Specimen Types

 Blood

Container

Red Top Tube

Collection Instructions

Specimen Type: Serum Red
Patient Preparation:
1. Specimens for testing should be collected prior to prostate manipulations such as digital rectal examination (DRE), prostatic massage, transrectal ultrasound (TRUS), and prostatic biopsy.
2. A 6-week waiting period between needle biopsy and specimen collection is recommended.
3. Specimens should not be collected from patients receiving therapy with high biotin (vitamin B7) doses (ie, >5 mg/day) until at least 8 hours following the last biotin administration.
Collection Container/Tube: Red top (serum gel/SST are not acceptable)
Submission Container/Tube: Plastic vial
Specimen Volume: 1 mL
Collection Instructions: Centrifuge, aliquot serum into plastic vial, and refrigerate serum within 3 hours of collection.
Specimen Minimum Volume: 0.75 mL
Specimen Stability Information:
Specimen TypeTemperatureTimeSpecial ContainerSerum RedFrozen150 days

Transport Instructions

Specimen Stability

Methodology

Immunoenzymatic Assay

Days Performed

Monday through Saturday

Performing Laboratory

Mayo Clinic Laboratories in Rochester

CPT

84153

PDM

 1759181

Only Orderable at Locations:

 Orderable Everywhere

Results
Component Name Base Name Common Name External Name
PROSTATE SPECIFIC ANTIGEN, S PSA PSA Prostate Specific Antigen